missing translation for 'onlineSavingsMsg'
Learn More

Pazopanib, MedChemExpress

Product Code. 16480946
Encompass_Preferred
Change view
Click to view available options
Quantity:
10 mg
50 mg
100 mg
200 mg
500 mg
Unit Size:
100mg
10mg
200mg
500mg
50mg
5 product options available for selection
Product selection table with 5 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
16480946 200 mg 200mg
16473708 10 mg 10mg
16440097 50 mg 50mg
16431546 500 mg 500mg
16414786 100 mg 100mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 5 options available.
5 options
This item is not returnable. View return policy
Product Code. 16480946 Supplier Medchem Express Supplier No. HY10208

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress Pazopanib (GW786034) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with IC50s of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.

Pazopanib (GW786034) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with IC50s of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.

Specifications

Chemical Name or Material Pazopanib
CAS 444731-52-6
Color White
Purity Grade Notes Research
Molecular Formula C21H23N7O2S
Quantity 200 mg
Synonym GW786034
Solubility Information DMSO : 62.5 mg/mL (142.85 mM; Need ultrasonic)
SMILES O=S(C1=CC(NC2=NC=CC(N(C3=CC4=NN(C(C)=C4C=C3)C)C)=N2)=CC=C1C)(N)=O
Molecular Weight (g/mol) 437.52
Formula Weight 437.52
Percent Purity 98.0%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.